Form 4: Teladoc Health Executive Nikolaos P. Nanis Reports Stock Transactions

Chief Technology Officer Nikolaos P. Nanis of Teladoc Health, Inc. reports acquisition and disposal of common stock and derivative securities.

Summary

• Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report includes transactions involving common stock, performance stock units (PSUs), and restricted stock units (RSUs).
• On March 1, 2024, Nanis acquired shares through the conversion of PSUs and RSUs.
• On March 4, 2024, Nanis sold 2,866 shares at $14.516 per share to cover tax obligations related to vesting of PSUs and RSUs.
• Following these transactions, Nanis directly owns 69,850 shares of Teladoc Health, Inc.
• Nanis also holds 4,437 Performance Stock Units and 19,134 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about ownership changes.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates